Race against time: new Blood-Clotting treatment aims to stop trauma bleeding faster
NCT ID NCT07218185
Summary
This study aims to see if a new, shelf-stable blood-clotting treatment (IFC) can be given faster than the standard treatment (Cryo-AHF) to people with severe bleeding after a traumatic injury. It will involve 320 adults arriving at trauma centers with life-threatening blood loss and a specific clotting problem. The main goal is to see if the new treatment shortens the time to get the needed clotting help and controls the bleeding effectively.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Barnes-Jewish Hospital, Washington University of Saint Louis
St Louis, Missouri, 63110, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jackson Memorial Hospital, University of Miami
Miami, Florida, 33136, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Colorado, Anschutz Medical Center
Aurora, Colorado, 80045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Maryland School of Medicine
Baltimore, Maryland, 21021, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.